DLA Pharmaceutical Prime Vendor (PPV) Program
$668,619Y01FY2022AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
The PPV contract enables DAIT/ NIAID to purchase brand name pharmaceutical products (ie: biologics) at a significantly discounted (50-60% cheaper) price for clinical trials where the institute holds the IND.
View original record on NIH RePORTER →